Biohaven Pharma (BHVN) Tops Q4 EPS by 28c
Biohaven Pharma (NYSE: BHVN) reported Q4 EPS of ($0.90), $0.28 better than the analyst estimate of ($1.18).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.
Biohaven Pharma (NYSE: BHVN) reported Q4 EPS of ($0.90), $0.28 better than the analyst estimate of ($1.18).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.